References
- Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007; 23:490 - 496; PMID: 17575488
- Schiffner-Rohe J, Jow S, K“ ster I, Lilie M. Inzidenz von Herpes zoster HZ in Deutschland, abstract accepted by DEGAM 2009
- Richard JL, Zimmermann HP. Herpes Zoster 1998–2001 2010;
- Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Micro 1993; 4:222 - 230
- Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995; 155:1605 - 1609; PMID: 7618983
- Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002; 19:471 - 475; PMID: 12356697
- Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18:350 - 354; PMID: 12441828
- Scott FT, Leedham-Green ME, Barrett-Muir WY, Hawrami K, Gallagher WJ, Johnson R, et al. A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 2003; 70:24 - 30; PMID: 12627483
- Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271 - 2284; PMID: 15930418
- Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67:241 - 251; PMID: 8951917
- Moore L, Remy V, Martin M, Beillat M, McGuire A. A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK 2010
- The Swiss Sentinel Surveillance Network 2010; http://www.bag.admin.ch/k_m_meldesystem/00736/00817/index.html?lang=en
- Federal statistics office of Switzerland 2010; http://www.bfs.admin.ch/bfs/portal/en/index.html
- Michel JP, Kempf W. Data collection related to the management of herpes zoster (HZ) and post-herpetic neuralgia (PHN) and demographic parameters in Switzerland 2007
- Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and postherpetic neuralgia in the United Kingdom. Epidemiol Infect 2008; 1 - 10; PMID: 18466661
- Cunningham AL, Dworkin RH. The management of post-herpetic neuralgia. BMJ 2000; 321:778 - 779; PMID: 11009498
- Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain 2005; 6:356 - 363; PMID: 15943957
- Bonneux L, Birnie E. The discount rate in the economic evaluation of prevention: a thought experiment. J Epidemiol Community Health 2001; 55:123 - 125
- Bos JM, Postma MJ, Annemans L. Discounting health effects in pharmacoeconomic evaluations: current controversies. Pharmacoeconomics 2005; 23:639 - 649; PMID: 16173156
- Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 2001; 19:3076 - 3090; PMID: 11312002
- Pellissier JM. Evaluation of the Cost-Effectiveness in the United States of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. Vaccine 2007; 25:8326 - 8337
- Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O'Brien B. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol 1998; 51:667 - 676; PMID: 9743315
- Szucs TD, Largeron N, Dedes KJ, Rafia R, Benard S. Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Curr Med Res Opin 2008; 24:1473 - 1483; PMID: 18413014
- Haldemann R, Luscher TF, Szucs TD. [Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study]. Praxis 2001; 90:539 - 545; PMID: 11550619
- Michel JP, Kempf W. Data collection related to the management of herpes zoster (HZ) and post-herpetic neuralgia (PHN) and demographic parameters in Switzerland 2008
Appendix References
- Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes 1997; Oxford Oxford University Press
- Briggs AH. Drummond M, McGuire AJ. Handling uncertainty in economic evaluation and presenting the results. Economic evaluation in health care 2001; Oxford Oxford University Press 172 - 214
- Bonneux L, Birnie E. The discount rate in the economic evaluation of prevention: a thought experiment. J Epidemiol Community Health 2001; 55:123 - 125
- Bos JM, Postma MJ, Annemans L. Discounting health effects in pharmacoeconomic evaluations: current controversies. Pharmacoeconomics 2005; 23:639 - 649